Legend Biotech Corp. (LEGN)
18.64
-0.55
(-2.87%)
USD |
NASDAQ |
Sep 11, 16:00
18.79
+0.15
(+0.80%)
After-Hours: 06:47
Legend Biotech Market Cap : 3.612B for Sept. 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 11, 2026 | 3.612B |
| September 10, 2026 | 3.718B |
| September 09, 2026 | 3.858B |
| September 08, 2026 | 3.970B |
| September 04, 2026 | 4.170B |
| September 03, 2026 | 4.214B |
| September 02, 2026 | 4.242B |
| September 01, 2026 | 4.094B |
| August 31, 2026 | 4.027B |
| August 28, 2026 | 3.852B |
| August 27, 2026 | 3.972B |
| August 26, 2026 | 4.007B |
| August 25, 2026 | 4.127B |
| August 24, 2026 | 4.058B |
| August 21, 2026 | 4.228B |
| August 20, 2026 | 4.120B |
| August 19, 2026 | 4.379B |
| August 18, 2026 | 4.247B |
| August 17, 2026 | 4.001B |
| August 14, 2026 | 3.947B |
| August 13, 2026 | 3.928B |
| August 12, 2026 | 4.001B |
| August 11, 2026 | 4.230B |
| August 10, 2026 | 4.003B |
| August 07, 2026 | 4.021B |
| Date | Value |
|---|---|
| August 06, 2026 | 3.581B |
| August 05, 2026 | 3.538B |
| August 04, 2026 | 3.553B |
| August 03, 2026 | 3.531B |
| July 31, 2026 | 3.445B |
| July 30, 2026 | 3.538B |
| July 29, 2026 | 3.501B |
| July 28, 2026 | 3.536B |
| July 27, 2026 | 3.579B |
| July 24, 2026 | 4.127B |
| July 23, 2026 | 4.370B |
| July 22, 2026 | 4.370B |
| July 21, 2026 | 4.372B |
| July 20, 2026 | 4.311B |
| July 17, 2026 | 4.135B |
| July 16, 2026 | 4.218B |
| July 15, 2026 | 4.279B |
| July 14, 2026 | 4.768B |
| July 13, 2026 | 4.783B |
| July 10, 2026 | 5.030B |
| July 09, 2026 | 5.086B |
| July 08, 2026 | 5.177B |
| July 07, 2026 | 5.141B |
| July 06, 2026 | 5.208B |
| July 02, 2026 | 5.555B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Gilead Sciences, Inc. | 178.36B |
| Arbutus Biopharma Corp. | 1.012B |
| AbbVie, Inc. | 454.35B |
| TG Therapeutics, Inc. | 8.249B |
| Capricor Therapeutics, Inc. | 486.37M |
Market Cap Related Metrics
| PS Ratio | 2.737 |
| Price to Book Value | 2.937 |
| Price | 18.64 |
| Earnings Yield | -2.71% |